Key Facts
Lilly at a Glance
A heritage 146 years strong: company founded on May 10, 1876
Headquarters located in Indianapolis, Indiana, U.S.A.
More than 38,000 employees worldwide
Approximately 9,100 employees engaged in research and development
Clinical research conducted in more than 55 countries
Research and development facilities located in 7 countries
Manufacturing plants located in 7 countries
Products marketed in 120 countries
Employees
as of December 31, 2022
Indianapolis: 11,279
Indiana (excluding Indianapolis): 115
U.S. (excluding Indiana): 6,521
Outside U.S.: 20,865
Worldwide total: 38,780
2022 Financials
dollars in millions, except per-share data
Revenue: $28,541.4
Net income as reported: $6,244.8
Net income non-GAAP: $7,186.4
Earnings per share (diluted) as reported: $6.90
Earnings per share (diluted) non-GAAP: $7.94
Dividends paid per share: $3.92
Research & Development
2022 Expenditures
$7,190.8 million
~$29 million/workday
R&D as a percentage of sales: 25.2%
Employees engaged in R&D activities: ~9,100
Percentage of total workforce: 23.6%
Cost of Pharmaceuticals
Average cost to discover and develop a new drug: $2.6 billion
Average length of time from discovery to patient: 10 years
Payments to Health Care Professionals
Lilly's Milestones of Caring and Discovery
Lilly's Position Statements